Michael Hauptmann

25PUBLICATIONS
145CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|Sep 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.

Thorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch

|Sep 13, 2025
Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects.

Shahin Roshani, Flora E van Leeuwen, Sara Rossetti

|Jun 13, 2025
Treatment and Outcome of Ductal Carcinoma in Situ for the German Federal States Berlin and Brandenburg in the Period 2007-2020.

Sandy Burmeister, Katarzyna Jóźwiak, Christiane Richter-Ehrenstein

|Apr 11, 2025
Author Correction: Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults.

Magda Bosch de Basea, Isabelle Thierry-Chef, Richard Harbron

|Mar 17, 2025
Building absolute breast cancer risk prediction models for women treated with chest radiation for Hodgkin lymphoma.

Sander Roberti, Flora E van Leeuwen, Michael Hauptmann

Pageof 5

Frequent Collaborators

4 joint publications

Sabine C Linn

4 joint publications

Flora E van Leeuwen

3 joint publications

Sander Roberti

3 joint publications

Wolfram Malter